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Key Points: 
1. Right ventricular (RV) dysfunction may be encountered in a wide variety of clinical 
scenarios
2. Identifying the underlying aetiology is important to optimising the RV. 
3. Key management principles involve optimising rate, rhythm, perfusion, and preload, 
whilst maintaining contractility and minimising afterload. 
4. ‘Traditional’ mechanical ventilation strategies may worsen RV dysfunction. 
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Learning Objectives:
By reading this article you should be to: 
 Describe a variety of conditions where right ventricular (RV) dysfunction might occur
 Describe a strategy for management of RV dysfunction including an approach to 
rate, rhythm, perfusion, preload, contractility, and afterload. 
 Be aware of the complex interaction between mechanical ventilation and RV 
dysfunction.
 Have a basic understanding of the mechanical support options available when 
pharmacological management fails. 
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Introduction
The importance of identifying and managing right ventricular (RV) dysfunction is becoming 
increasingly recognised by both anaesthetist and intensivist. In the face of an ageing 
population, with a broad range of increasingly complex comorbidities, the importance of RV 
function is applicable to a far wider population than those undergoing cardiothoracic 
surgery. Early recognition of RV dysfunction is essential to prevent failure and improve 
morbidity and mortality. An approach to RV structure and function was discussed in part 
one of this series with the aim of this second article to provide an overview of the clinical 
conditions leading to RV dysfunction and outline an approach to managing these patients.1
Right ventricular failure (RVF) is a heterogeneous syndrome, with a wide variety of 
aetiologies (both acute and chronic) requiring individualised treatment.2 Whilst RVF lacks a 
validated consensus definition, the term acute right heart syndrome (ARHS) has recently 
been described, and is defined as a rapidly progressive syndrome with systemic congestion 
resulting from impaired RV filling and or reduced RV flow output.2  
A high index of suspicion is required in patients with potential acute RV dysfunction as signs 
and symptoms may be non-specific. Acute signs of RVF are mainly a result of low cardiac 
output (CO) or systemic venous congestion and include signs of hypoperfusion with 
deranged liver function tests, elevated urea and creatinine, high lactate, and low venous 
oxygen saturations, all of which are non-specific to the diagnosis of RV failure. Signs and 
symptoms of chronic RV failure, such as ascites, exertional dyspnoea, reduced exercise 
tolerance, and ankle swelling may not always be present. Early use of transthoracic 
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echocardiography (TTE) is recommended in those with a suspicion of RV failure to aid the 
early diagnosis in a challenging cohort of patients with limited specific clinical signs.3
Clinical Conditions in which RV failure may be encountered
RV function can be impaired by either volume or pressure overload states or a reduction in 
myocardial contractility. Dysfunction is triggered by an injury or stress to the RV with 
adaptation dependant on the nature of the insult, the duration of the disease, and time of 
onset (i.e. birth, childhood or adulthood). Acute events, as seen in myocardial infarction 
(MI) or pulmonary embolism (PE), may quickly progress to RV failure due to impaired 
contractility or acutely increased afterload. In chronic diseases, such as pulmonary 
hypertension (PH) or congenital cardiac disease, a gradual increase in RV afterload allows 
adaptive mechanisms to develop which preserve CO over a longer period of time before 
decompensation occurs. 
Generally, the RV adapts better to volume overload, as seen with tricuspid regurgitation 
(TR) and atrial septal defects (ASDs), and can withstand these conditions for a long period of 
time without significant change in RV systolic function. Acute pressure overload, as seen in 
PE, leads to a rapid rise in pulmonary vascular resistance (PVR), increased afterload and RV 
wall tension, which quickly leads to RV dilatation and failure. Chronic pressure overload, 
commonly seen in PH, results in the RV being able to adapt as the pressure increases 
gradually over time. Multiple compensatory measures exist in chronic pressure overload 
including myocyte hypertrophy, expansion of the extracellular matrix, reduction in wall 
stress, and upregulation of neurohormonal systems. Over time, the gradual increase in 
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afterload results in a decrease in contractility, leading to progressive RV dilation and 
ultimately failure. 
When considering the aetiology of RV dysfunction, it can be useful to categorise into those 
affecting preload, afterload and contractility. Increased preload may occur in TR and ASDs.  
Increased afterload may occur due PH and PE. Decreased contractility may be encountered 
in RV infarction, arrhythmias or sepsis.  In critically ill patients, RV dysfunction can often be 
multifactorial e.g. with sepsis induced acute respiratory distress syndrome (ARDS) where RV 
function may be impaired by both increased afterload and reduced contractility. 
 Pulmonary Hypertension 
PH is defined by a mean pulmonary artery pressure ≥25 mm Hg at rest, and is the 
commonest cause of RV failure.4 The World Health Organisation classifies PH into 5 broad 
classifications: 1) pulmonary arterial hypertension, 2) PH secondary to left heart disease, 3) 
PH associated with lung disease, 4) chronic thromboembolic PH and 5) miscellaneous 
including haematological, metabolic and systemic disorders.4 Classifications 1,3, and 4 are 
‘precapillary’ and demonstrate a low or normal pulmonary capillary wedge pressure (a 
surrogate measure of left atrial pressure). 
 In PH, remodelling of the pulmonary vasculature, hypoxic vasoconstriction and disruption 
and fibrosis of small pulmonary vessels result in a steady increase in PVR. Increased 
afterload and disruption of neuroendocrine and autocrine signals leads to cardiomyocyte 
loss, myocardial ischaemia and remodelling. Initially, this increased afterload can be 
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compensated for by RV hypertrophy, but eventually, the RV can no longer compensate and 
dilatation and dysfunction occur.  The RV’s ability to adapt to pressure overload determines 
prognosis in PH with a dilated RV shown to predict poor survival.5 
Managing patients with PH in a critical care setting can be challenging and complex; 
pulmonary vasodilators, less commonly used in a general ICU environment, may be required 
with consideration given to early advice from a PH centre.6 Condliffe et al have recently 
published ‘Critical Care Management of Pulmonary Hypertension’ which provides an in-
depth review of PH in the ICU setting.6
Special attention should be given to patients with preexisting PH undergoing surgery as they 
are at high risk of deterioration. The chosen anaesthetic technique should aim to prevent 
further iatrogenic increases in PAP by preventing hypoxia, hypercapnia, and acidosis. The 
use of PEEP, intraoperative patient positioning, and pneumoperitoneum can all increase 
afterload. Intraoperative invasive monitoring is likely to be required and the use of 
transoesophageal echocardiography (TOE) and CO monitoring devices may be appropriate. 
Neuraxial techniques can be used; however, consideration should be given to the risk of 
cardiovascular instability with sympathetic block. These patients are likely to require critical 
care following surgery with high-risk of post-operative RV failure. Depending on the nature 
and urgency of the surgery, referral to a PH centre for advice may be appropriate. 
 Left Ventricular (LV) Failure
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The commonest cause of PH is left-sided heart failure which includes LV systolic dysfunction, 
LV diastolic dysfunction and left-sided valvular heart disease.4 LV failure is classified as post 
capillary PH (class II) and is associated with a high pulmonary capillary wedge pressure.4 In 
this instance, PH develops occurs as a result of passive backward transmission of raised left 
sided filling pressures. Associated  RV dysfunction often goes unrecognised despite a 
prevalence of around one fifth of patients with LV failure.7 RV failure is an important 
independent predictor of survival in patients with LV failure.7 As with all cases of RV failure, 
monitoring of both the LV and RV with echocardiography is essential.  In patients with RV 
failure as a result of raised left sided filling pressures, benefit may be derived from left heart 
failure management strategies including revascularisation, diuresis, and the use of beta 
blockers and angiotensin converting enzyme inhibitors. In some preoperative patients, it 
may be beneficial to delay surgery in order to optimise heart failure management prior to 
surgery. 
 Chronic Obstructive Pulmonary Disease (COPD)
COPD is the most common cause of cor pulmonale and leads to an increase in RV afterload 
secondary to changes in pulmonary vascular structure and mechanics, and lung 
hyperinflation. Patients with COPD who subsequently develop RV dysfunction have an 
increased risk of admission to hospital and mortality.8 
It is often not appreciated that these changes are not just limited to those with severe lung 
disease; studies demonstrate remodelling of the pulmonary vasculature occurs in those with 
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mild disease and in smokers with normal lung function.9 As such, there is good evidence to 
show that patients with mild to moderate COPD (well within the realms of lung function 
seen in patients presenting for a wide range of elective surgeries) have exercise limitation 
resulting from cardiac (i.e. RV) rather than respiratory insufficiency. Arguably, the COPD 
population should be considered ‘at risk’ of RV dysfunction during the perioperative period 
and may be less tolerant of the stresses of mechanical ventilation and critical illness. The 
development of disproportionate haemodynamic collapse following intubation in the COPD 
patient with ‘single organ’ postoperative respiratory failure is a classic example of this.
 Pulmonary Embolism (PE)
PE is the commonest cause of acute RV dysfunction; assessment of RV function is essential 
as mortality is directly related to the extent of RV failure.10 Mechanical obstruction of 
pulmonary vessels results in acutely increased RV afterload. Acute dilatation and stretch of 
the RV muscle occurs when more than 30% of the pulmonary vasculature is blocked, 
increasing RV wall tension with an increasing oxygen demand whilst simultaneously 
decreasing perfusion. 11 In most cases of PE, as resolution of the embolus occurs over time, 
pulmonary artery pressures (PAP) decline and RV function returns to normal.  
Chronic thromboembolic PH (CTEPH) is a rare complication of PE and occurs as a result of 
incomplete resolution of the clot with the formation of a fibrotic and flow limiting thrombus 
within the pulmonary vasculature. These changes lead to an increase in afterload with 
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remodelling of both the pulmonary vasculature and the RV. Pulmonary endarterectomy may 
be appropriate for some patients; however, RV dysfunction may persist following surgery as 
a result of the extent of RV remodelling which has taken place.12
 Acute Respiratory Distress Syndrome
Acute cor pulmonalae has been reported in 20-25% of patients with ARDS with good 
evidence to suggest that RV dysfunction is independently associated with poor outcome.13 A 
high index of suspicion is therefore required for the potential diagnosis of PH and RV 
dysfunction in those with ARDS as the clinical signs are often non-specific.  
ARDS causes direct injury to the pulmonary circulation caused by hypoxic vasoconstriction, 
extrinsic vascular compression as a result of interstitial oedema, vasoconstrictor mediator 
release, and blood vessel remodelling. Endothelial dysfunction is a common feature 
alongside mechanical obstruction as a consequence of thromboemboli particularly in the 
larger pulmonary arteries, veins, and lymphatics whilst smaller vessels become occluded by 
neutrophils and platelets. 14 This leads to an increase in PVR , RV afterload, the development 
of PH and RV failure.  In patients with ARDS, these effects are magnified as airway pressures 
rise in combination with the pulmonary vasoconstrictive effects of hypoxia and hypercapnia. 
It is increasingly being recognised that modern ventilatory practices with low tidal volumes 
and high PEEP have the potential to adversely affect RV function, with some experts 
recommending an ‘RV protective approach’ to mechanical ventilation in ARDS, such that 
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PEEP is manipulated in parallel with echocardiographic assessment of the RV. Such an RV 
protective strategy focuses on limiting plateau pressure to reduce lung stress, improving 
oxygenation to limit the effect of hypoxic vasoconstriction and preventing hypercapnia.15 
Tidal volume and PEEP should aim to maintain a plateau pressure <27cmH20, a driving 
pressure <18cmH20 and ideally a PaC02 <48mmHg.15 If the respiratory rate is adjusted, this 
should be done carefully as this may induce intrinsic PEEP and dynamic hyperinflation 
worsening RV dysfunction. Ventilation in the prone position has been shown to induce 
alveolar recruitment and reduce RV afterload.16
 Obesity and Obstructive Sleep Apnoea 
Obesity is an independent risk factor for cardiovascular disease and has been shown to 
cause a wide spectrum of cardiovascular changes which can ultimately result in heart 
failure. Obesity can lead to RV dysfunction as a result of increased CO, obesity 
hypoventilation syndrome and obstructive sleep apnoea (OSA). Studies have shown the 
presence of RV dilatation, increased RV wall thickness and subclinical RV diastolic and 
systolic impairment may be present in young obese patients with no pre-existing 
cardiovascular disease. 17
In OSA, hypoxic pulmonary vasoconstriction occurs during apnoeic episodes leading to 
remodelling of the pulmonary microcirculation increasing PVR, and ultimately leading to the 
development of PH and subsequent RV dysfunction.18 Negative intrathoracic pressure, 
occurring during inspiration against an occluded pharynx, increases venous return, and RV 
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preload.18 Co-existing cardiovascular disease and hypoxaemia may also play an important 
role in RV dysfunction in this patient population. Imaging of the RV by TTE can be 
challenging in this cohort of patients and consideration may be given to more advanced 
techniques.  
Careful attention to mechanical ventilation strategies is also required to prevent atelectasis 
but prevent further RV dysfunction (necessitating a similarly balanced ventilation strategy as 
described in ARDS). 
 Right ventricle myocardial infarction (RVMI)
As the RV is supplied by the right coronary artery (RCA) in 80% of the population, RCA 
occlusion can lead to significant RV ischaemia. Generally, the RV is considered to more 
tolerant of an ischemic insult compared with the LV as a result of coronary perfusion 
occurring throughout the cardiac cycle, and reduced myocardial oxygen demand19. Patients 
with a proximal RCA MI, however, have an increased risk of tachyarrhythmia, cardiogenic 
shock and death because of the interruption of the blood flow to the AV node and the lack 
of collateral blood supply present in the RV. Prognosis in RVMI is dependent on the location 
of the MI, presence of complications, preexisting RV dysfunction, and successful coronary 
reperfusion. Similar to LVMI, patients who survive RVMI, may recover their systolic function 
following the initial ischaemic episode as ‘stunning’ resolves. 
 Congenital Heart Disease
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Several different types of congenital heart disease are associated with RV dysfunction. Both 
atrial and ventricular septal defects (A- and V-SD) with left to right shunt and tricuspid and 
pulmonary regurgitation may lead to volume overloaded RV failure. Chronically increased 
pulmonary blood flow can occur in large septal defects leading to pulmonary endothelial 
damage, thrombosis, RV hypertrophy and pulmonary vascular remodelling. If unchecked, 
progressive hypertrophy and increasing right sided systolic pressure result in 
‘suprasystemic’ right sided pressures and reversal of the initially left-to-right shunt. This 
results in right-to-left shunting and consequent systemic hypoxemia as seen in 
Eisenmenger’s syndrome. 19 20
Pressure-overloaded RV failure occurs with pulmonary stenosis, RV outflow tract (RVOT) 
obstruction after correction of tetralogy of Fallot (TOF), and repair of transposition of the 
great arteries. Whilst the RV is initially able to adapt, (if untreated) longstanding obstruction 
leads to progressive TR and RV dilation and failure.20 Over time pulmonary regurgitation 
leads to progressive RV dilatation necessitating timely PV replacement before RV 
dysfunction ensues.20 Adult patients with TOF repaired in childhood are becoming an 
increasingly large cohort in congenital cardiac centres. 
 Cardiac Surgery
A degree of RV dysfunction following cardiac surgery is commonplace; however, the 
underlying aetiology is not clear. Besides the effects of myocardial stunning resulting from 
direct myocardial ischaemia during cardiopulmonary bypass, the RV is particularly 
susceptible to post-operative dysfunction because of air embolization (to which the RV is 
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particularly predisposed as a result of the anterior location of the right coronary ostia), and 
increased PVR postoperatively. Where systemic vasodilatation is common following 
cardiopulmonary bypass, PVR commonly rises as a result of the activation of inflammatory 
mediators, the accumulation of extravascular lung water, persistent pulmonary de-
recruitment and protamine-induced PH.
PH, RV dilatation and dysfunction, and functional TR are common sequelae of mitral valve 
disease. At the time of mitral valve surgery, the tricuspid vale (TV) may also be repaired. 
Careful attention to the RV following TV surgery is paramount. Pre-operatively TR can lead 
to overestimation of baseline RV function as it is ‘flattered’ by the presence of TR (i.e. the 
ease of emptying when blood may flow in an anterograde or retrograde direction can make 
the function ‘look’ better than it is). Repair of the valve can then lead to an effective 
increase in afterload which may unmask impaired RV function. 
 Left Ventricular Assisted Devices (LVAD)
LVADs are used as a bridge to transplant or recovery in patients with severe heart failure. An 
inlet cannula is inserted into the LA or LV cavity, whilst an outflow graft is attached to the 
ascending aorta providing isolated support to the left-side of the heart.   Adequacy of RV 
function is a major determinant of outcome following LVAD insertion. In comparison to the 
low cardiac output state encountered pre-operatively, following LVAD implantation, the RV 
is challenged by the need to match the increased LV output which leads to an effective 
increase in preload. In addition, unloading of the LV by a VAD can alter the shape and size of 
the RV leading to a direct effect on function.21
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 Heart Transplantation
Despite advances in the perioperative management of heart transplantation, acute RV 
failure still accounts for a significant number of complications and early deaths. Whilst the 
aetiology for RV failure following transplantation is multifactorial, two predominant 
mechanisms are described. Firstly, that of an ischaemic insult to the RV occurring as a result 
of prolonged ischaemic time and sub-optimal myocardial protection leading directly to 
primary graft failure. Secondly, the presence of pre-existing or acquired PH in the recipient 
can result in the exposure of the previously ‘afterload-naive’ (and therefore not adapted) 
transplanted organ to acutely increased afterload.
Management:
The management of RV failure should naturally aim to identify and treat any underlying 
aetiology. Generic treatment goals include optimising rate, rhythm, perfusion, preload, 
augmenting myocardial contractility and minimising afterload (Figure 1). This requires a 
careful balance of cardiac filling combined with vasopressor and inotropic support. In rare 
cases, surgical management may be required in the form of mechanical circulatory support. 
 Optimise rate and rhythm
In general, it is considered preferable to keep the RV beating faster and where possible in 
sinus rhythm (SR). A relatively high heart rate (it is not uncommon to pace the immediately 
post-transplanted heart at 110 bpm), prevents excessive RV distention and subsequent 
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distortion of the LV and minimises TR. Additionally in conditions of failure where stroke 
volume may be limited, a higher heart rate promotes cardiac output. Clinicians should 
always be aware however of the effects of tachycardia on the LV blood supply and on its 
function. 
In theory, preservation of SR offers significant haemodynamic benefits, improving 
ventricular preload as well as improving atrial emptying and reducing atrial pressures. In 
many patients, non-sinus rhythm is a chronic situation however; attempts to restore SR 
through chemical or electrical cardioversion should therefore be reserved for circumstances 
where acute or paroxysmal arrhythmias are causing or exacerbating a patient’s condition.
 Maintaining Perfusion
The importance of maintaining systemic arterial pressure, and right coronary perfusion 
pressure is often under-appreciated in RV dysfunction where systemic hypotension can be 
detrimental to the failing RV. Vasoconstrictor agents, such as noradrenaline or vasopressin 
(Table 1), are often required to maintain systemic pressure, indirectly resulting in improved 
RV function and global tissue perfusion. 
Intra-aortic balloon pump counter pulsation (IABP) is a commonly used circulatory assist 
device improving coronary and systemic blood flow.22 Whilst these devices are generally 
considered to provide left sided support; improvement of right coronary perfusion can aid 
RV function. The IABP inflates and deflates in harmony with the cardiac cycle; as diastolic 
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aortic pressure is augmented, coronary perfusion pressure is increased, improving coronary 
blood flow and increasing myocardial oxygen supply. 
 Optimise preload
Optimising RV preload by ensuring adequate filling pressure is important in patients with RV 
dysfunction; even a functionally impaired ventricle has an optimal level of filling. Given the 
potential for deleterious effects of over-distention however, it is common practice to assess 
fluid responsiveness in patients with RV dysfunction by using small volume fluid boluses (50-
100ml) whilst paying close attention to CVP. In patients with RV dilatation, any increase in 
intravascular volume can worsen dilatation and further impair LV diastolic filling. In the 
dilated RV, marked diuresis is often warranted to offload the ventricle and reduce right-
sided filling pressures. 
Exaggerated, ventilation induced (i.e. in response to cyclically varying afterload) changes in 
SV and CO are common in the failing RV and can easily be misinterpreted as signs of ‘fluid 
responsiveness’, rendering monitors assessing SV or systolic pressure variation less useful in 
this context. Often the only reliable method of assessing preload responsiveness is the 
judicious administration of a fluid bolus and observing the net change in SV or CO using an 
appropriate CO monitor.
 Reduce afterload
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Minimising afterload is a key component of RV management, though many patients 
presenting with RV failure have chronic lung or cardiac diseases and consequently PH that 
cannot easily be reversed. Iatrogenic increases in PVR should be avoided by careful 
avoidance of hypoxia, hypercapnia and acidosis. When ventilating patients with RV failure 
airway pressures should be minimised and PEEP used judiciously; both atelectasis and 
excessive PEEP will increase PVR (Figure 2). Again, these goals appear in conflict to those 
employed in patients with ARDS, where permissive hypercapnia and higher levels of PEEP 
are commonplace. 
Intravenous (IV) or inhaled pulmonary vasodilators may be used to reduce afterload by 
targeting pathways implicated in PH. IV pulmonary vasodilators (e.g. GTN, flolan, 
inodilators) cause indiscriminate vasodilation of the pulmonary vascular bed, blunting 
hypoxic pulmonary vasoconstriction, leading to a worsening of any ventilation-perfusion 
mismatch (V/Q) and potentially causing hypoxia.  Systemic vasodilation occurs in parallel 
and can cause systemic hypotension. 
Inhaled vasodilators, such as nitric oxide, reduce PVR only in areas of the lung that are well 
ventilated and so improve the V/Q matching by increasing flow to these areas, improving 
oxygenation and decreasing PVR. Nitric oxide has a fast-onset of action with a short half-life 
and has been shown to improve RV systolic function, mixed venous oxygen saturations and 
haemodynamics in patients with acute RV failure. Nitric oxide may be of benefit in the peri-
operative and early post-operative period in patients with PH during cardiac surgery. There 
is evidence for a reduction in PAP and an improvement in hypoxia in other clinical scenarios 
such as ARDS, PE, and COPD; however, the evidence for an improvement in overall outcome 
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is lacking.  Disadvantages include expense, the need for toxicity monitoring, platelet 
inhibition, prolonged bleeding time and the potential for rebound hypoxaemia and PH. 
Weaning of nitric oxide can be challenging and slow weaning over hours to days may be 
required to avoid vasoconstriction and rebound pulmonary hypertension or hypoxaemia. 
 Oral phosphodiesterase type-5 inhibitors, such as sildenafil, reduce PVR and improve RV 
contractility but caution should be exercised because of their long terminal half-life (4-
18hours) and risk of systemic hypotension as a result of systemic vasodilatation.  In practice, 
these agents tend to be used in stable disease rather than in the acute phase.
 Optimise contractility
Inodilatory vasoactive drugs, such as dobutamine, a beta agonist, or milrinone a 
phosphodiesterase-3 inhibitor, are a natural choice in RV dysfunction promoting increased 
contractility with a simultaneous reduction in afterload (Table 1). Both agents cause a 
reduction in SVR and can lead to profound systemic hypotension, especially with milrinone. 
As such, systemic vasoconstrictors are often required in conjunction with ino-dilators to 
counteract the side effects described. 
Levosimendan, a calcium sensitizer, may improve coronary perfusion and contractility 
without increasing myocardial demand; however, its role in RV failure needs further 
exploration. 
 Mechanical Support
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In isolated RV failure refractory to medical therapy or RV failure in the context of an LV 
support device several options exist for mechanical circulatory support of the RV. It is 
important to consider mechanical support early in order to prevent irreversible end organ 
damage.
Peripheral venoarterial extracorporal membrane oxygenation (ECMO - in contrast to 
venovenous ECMO) provides respiratory and biventricular support via cannulae in the right 
atrium (inserted via a peripheral vein) and in the subclavian or femoral artery.
Surgically implanted VADs provide isolated RV support classically via cannulae in the RA or 
RV and an outflow cannula in the pulmonary artery. In recent years, so called 
‘percutaneously inserted’ VAD devices such as the Impella RP and TandemHeart RVAD 
devices have become increasingly popular, providing isolated RV support without the need 
for sternotomy by accessing the pulmonary circulation via a transvalvular systemic venous 
approach.
Conclusions
RV dysfunction and failure can occur as a result of a wide variety of pathophysiology and is 
becoming more frequent in the general anaesthetic and intensive care population. Initial 
management should aim to identify potential underlying reversible causes, optimise preload 
and reduce afterload. Close attention should be paid to rate, rhythm and perfusion. 
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Pharmacological management may include a combination of inotropes, vasopressors, and 
pulmonary vasodilators. 
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MCQs
Question1:
A 64-year-old male is admitted to ICU with Type 1 respiratory failure. His chest xray findings 
are consistent with acute respiratory distress syndrome (ARDS). He has an endotracheal 
tube placed and is ventilated. His current ventilation settings are Fi02 0.9, TV 550ml, RR 18, 
PEEP 8cmH20. His observations include BP 74/47mmHg MAP 58, HR 108bpm, lactate 6, 
venous oxygen saturations 48%. The following statements are true:
a) An increased pulmonary vascular resistance (PVR) occurs during mechanical ventilation 
because of alveolar distension and extra-alveolar capillary compression.
b) A bedside transthoracic echocardiograph would be an appropriate investigation in this 
patient.
c) A driving pressure of >18cm H20 is considered a risk factor for acute cor pulmonale. 
d) Proning may be beneficial in this patient to increased afterload. 
e) ‘RV protective’ ventilation strategies include adjusting tidal volume and PEEP to achieve a 
plateau pressure of >27cm H20
Answers:
a) True. Alveolar distention during mechanical ventilation leads to compression of extra-
alveolar capillaries increasing pulmonary vascular resistance (PVR) and RV afterload. In 
patients with ARDS, these effects are magnified as airway pressures rise in combination 
with the pulmonary vasoconstrictive effects of hypoxia and hypercapnia.
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b) True. This patient is demonstrating non-specific signs of RV dysfunction including evidence 
of hypoperfusion. A bedside TTE may demonstrate evidence of RV dysfunction which occurs 
in around 15% of patients with ARDS. 
c) True. Risk factors for acute pulmonale include an Pa02/Fi02 of < 150mmHg (20 kPa), PaCo2 > 
48mmHg (6.3kPa) and a driving pressure of > 18cm H20.
d) False. Proning could be useful in this patient as it has been shown to reduce afterload and 
improve alveolar recruitment. 
e) False. Tidal volume and PEEP should aim to maintain a plateau pressure less than 27cmH20, 
a driving pressure < 18cmH20 and ideally a PaC02 < 48mmHg
Question 2:
Appropriate statements regarding pharmacological management of right ventricular failure 
(RVF) include:
a) Milrinone leads to an increase in pulmonary vascular resistance as a result of its role as a 
PDE3 inhibitor 
b) Noradrenaline works on the 1 and 1receptors leading to vasoconstriction and increased 
myocardial oxygen delivery. 
c) Sildenafil can be inhaled via a nebuliser, administered intravenously or orally. 
d) Vasopressin causes pulmonary vasodilatation 
e) Nitric oxide has a half-life of less than 5 seconds
Answers:
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Question 2 
a. False. Milrinone is an ino-dilator that works on the PDE3 receptor causing a decrease 
in pulmonary and systemic vascular resistance.
b. True. Noradrenaline works on the 1, 1 with effects including vasoconstriction, 
increased systemic and pulmonary vascular resistance, and increased myocardial 
oxygen delivery. 
c. False. Sildenafil has an oral and IV preparation but no nebulised form. Other 
pulmonary vasodilators such as prostacyclin may be given in the nebulised form. 
d. True. Vasopressin causes pulmonary vasodilatation as a result of its stimulation of 
endothelial nitric oxide. 
e. True. Inhaled NO reacts with oxidised haemoglobin to produce methaemoglobin 
with a half-life of less than 5 seconds. 
Question 3:
Regarding clinical conditions associated with right ventricular dysfunction: 
a. Right ventricular myocardial infarction occurs traditionally because of occlusion 
of the left anterior descending artery.
b. Atrial septal defects (ASD) can lead to volume overloaded RV failure. 
c. Repair of the tricuspid valve during cardiac surgery may lead to an increase in 
preload.
d. Pre-existing pulmonary hypertension is a risk factor for developing post-
operative RV dysfunction in cardiac transplant patients. 
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e. Following left ventricular assisted device insertion, the RV has to work harder as 
a result of an increase in contractility. 
Answers 3:
a. False. RVMI classically occurs because of an occlusion of the right coronary artery. 
b. True. ASD defects are associated with volume overloaded RV failure. Other causes 
include VSDs, pulmonary regurgitation and tricuspid regurgitation. 
c. False. Repair of the tricuspid valve leads to an effective increase in afterload which 
may affect RV function. 
d. True. The transplanted heart may be exposed to increased afterload from pre-
existing pulmonary hypertension resulting in RV failure. 
e. False.  In comparison to the low cardiac output state encountered pre-operatively, 
following LVAD implantation, the RV has to work harder to match the increased LV 
output which leads to an effective increase in preload.
Question 4: 
Regarding the aetiology of right ventricular failure, the following statements are true:
a. During cardiac surgery, RV dysfunction may occur because of air embolism.
b. Negative intra-thoracic pressure, encountered in OSA, increases venous return and 
consequently RV preload. 
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c. Patients with large VSD defects will present with pressure-overloaded RV failure. 
d. RV failure may be encountered following LVAD insertion as a result of an increased preload. 
e. LV failure is classified as WHO Class 1 Pulmonary Hypertension. 
Answers:
a. True. The RV is particularly susceptible to post-operative dysfunction because of air 
embolization. The RV is particularly predisposed because of the anterior location of the right 
coronary ostia.
b. True. The negative intra-thoracic pressure, occurring during inspiration against an occluded 
pharynx, increases venous return, and RV preload.
c. False. Ventricular septal defects (A- and V-SD) with left to right shunt and tricuspid and 
pulmonary regurgitation may lead to volume-overloaded RV failure.
d. True. Following LVAD implantation, the RV is challenged by the need to match the increased 
LV output which leads to an effective increase in preload and therefore potential RV failure. 
e. False. LV failure is classified as post-capillary PH (WHO class II PH) and is associated with a 
high pulmonary capillary wedge pressure
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Figure 1: Management of Right Ventricular Failure Algorithm. 
NO: nitric oxide. PH: pulmonary hypertension. DCCV: direct current cardioversion. CVP: 
central venous pressure. CVVH: continuous venous-venous hemofiltration. IABP: intra-aortic 
balloon pump. ECMO: extra-corpeal membrane oxygenation. VAD: ventricular assist device. 
HR: Heart rate. SR: sinus rhythm. IV: Intravenous. 
Figure 2. Schematic representation of the relationship between lung volume and 
pulmonary vascular resistance. 
The relationship of PVR and lung volumes. Atelectasis compresses extra-alveolar bloods 
vessels which increases PVR. Alveolar distention, occurring at high lung volumes, 
compresses intra-alveolar blood vessels which increases PVR. 
RV - Residual volume (RV). Functional Residual Capacity (FRC). Total Lung Capacity (TLC).
Table 1. Commonly used pharmacological agents in RV failure.
IV: intravenous. Neb: Nebulised. SVR: systemic vascular resistance. PVR: pulmonary vascular 
resistance. PH: Pulmonary hypertension. a A loading dose of milrinone may be given. 
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MCQs
Question1:
A 64-year-old male is admitted to ICU with Type 1 respiratory failure. His chest x-ray findings 
are consistent with acute respiratory distress syndrome (ARDS). He has an endotracheal 
tube placed and is ventilated. His current ventilation settings are Fi02 0.9, TV 550ml, RR 18, 
PEEP 8cmH20. His observations include BP 74/47mmHg MAP 58, HR 108bpm, lactate 6, 
venous oxygen saturations 48%. The following statements are true:
a) An increased pulmonary vascular resistance (PVR) occurs during mechanical ventilation due 
to alveolar distension and extra-alveolar capillary compression.
b) A bedside transthoracic echocardiograph would be an appropriate investigation in this 
patient.
c) A driving pressure of >18cm H20 is considered a risk factor for acute cor pulmonale. 
d) Proning may be beneficial in this patient to increased afterload. 
e) ‘RV protective’ ventilation strategies include adjusting tidal volume and PEEP to achieve a 
plateau pressure of >27cm H20
Answers:
a) True. Alveolar distention during mechanical ventilation leads to compression of extra-
alveolar capillaries increasing pulmonary vascular resistance (PVR) and RV afterload. In 
patients with ARDS, these effects are magnified as airway pressures rise in combination 
with the pulmonary vasoconstrictive effects of hypoxia and hypercapnia.
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b) True. This patient is demonstrating non-specific signs of RV dysfunction including evidence 
of hypoperfusion. A bedside TTE may demonstrate evidence of RV dysfunction which occurs 
in around 15% of patients with ARDS. 
c) True. Risk factors for acute pulmonale include an Pa02/Fi02 of < 150mmHg (20 kPa), PaCo2 > 
48mmHg (6.3kPa) and a driving pressure of > 18cm H20.
d) False. Proning could be useful in this patient as it has been shown to reduce afterload and 
improve alveolar recruitment. 
e) False. Tidal volume and PEEP should aim to maintain a plateau pressure less than 27cmH20, 
a driving pressure < 18cmH20 and ideally a PaC02 < 48mmHg
Question 2:
Appropriate statements regarding pharmacological management of right ventricular failure 
(RVF) include:
a) Milrinone leads to an increase in pulmonary vascular resistance due to its role as a PDE3 
inhibitor 
b) Noradrenaline works on the 1 and 1receptors leading to vasoconstriction and increased 
myocardial oxygen delivery. 
c) Sildenafil can be inhaled via a nebuliser, administered intravenously or orally. 
d) Vasopressin causes pulmonary vasodilatation 
e) Nitric oxide has a half-life of less than 5 seconds
Answers:
Question 2 
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a. False. Milrinone is an ino-dilator that works on the PDE3 receptor causing a decrease 
in pulmonary and systemic vascular resistance.
b. True. Noradrenaline works on the 1, 1 with effects including vasoconstriction, 
increased systemic and pulmonary vascular resistance, and increased myocardial 
oxygen delivery. 
c. False. Sildenafil has an oral and IV preparation but no nebulised form. Other 
pulmonary vasodilators such as prostacyclin may be given in the nebulised form. 
d. True. Vasopressin causes pulmonary vasodilatation due to its stimulation of 
endothelial nitric oxide. 
e. True. Inhaled NO reacts with oxidised haemoglobin to produce methaemoglobin 
with a half-life of less than 5 seconds. 
Question 3:
Regarding clinical conditions associated with right ventricular dysfunction: 
a. Right ventricular myocardial infarction occurs traditionally due to occlusion of 
the left anterior descending artery.
b. Atrial septal defects (ASD) can lead to volume overloaded RV failure. 
c. Repair of the tricuspid valve during cardiac surgery may lead to an increase in 
preload.
d. Pre-existing pulmonary hypertension is a risk factor for developing post-
operative RV dysfunction in cardiac transplant patients. 
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e. Following left ventricular assisted device insertion, the RV has to work harder 
due to an increase in contractility. 
Answers 3:
a. False. RVMI classically occurs due to occlusion of the right coronary artery. 
b. True. ASD defects are associated with volume overloaded RV failure. Other causes 
include VSDs, pulmonary regurgitation and tricuspid regurgitation. 
c. False. Repair of the tricuspid valve leads to an effective increase in afterload which 
may affect RV function. 
d. True. The transplanted heart may be exposed to increased afterload from pre-
existing pulmonary hypertension resulting in RV failure. 
e. False.  In comparison to the low cardiac output state encountered pre-operatively, 
following LVAD implantation, the RV has to work harder to match the increased LV 
output which leads to an effective increase in preload.
Question 4: 
Regarding the aetiology of right ventricular failure, the following statements are true:
a. During cardiac surgery, RV dysfunction may occur due to air embolism.
b. Negative intra-thoracic pressure, encountered in OSA, increases venous return and 
consequently RV preload. 
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c. Patients with large VSD defects will present with pressure-overloaded RV failure. 
d. RV failure may be encountered following LVAD insertion due to an increased preload. 
e. LV failure is classified as WHO Class 1 Pulmonary Hypertension. 
Answers:
a. True. The RV is particularly susceptible to post-operative dysfunction due to air 
embolization. The RV is particularly predisposed due to the anterior location of the right 
coronary ostia.
b. True. The negative intra-thoracic pressure, occurring during inspiration against an occluded 
pharynx, increases venous return, and RV preload.
c. False. Ventricular septal defects  (A- and V-SD) with left to right shunt and tricuspid and 
pulmonary regurgitation may lead to volume-overloaded RV failure.
d. True. Following LVAD implantation, the RV is challenged by the need to match the increased 
LV output which leads to an effective increase in preload and therefore potential RV failure. 
e. False. LV failure is classified as post-capillary PH (WHO class II PH) and is associated with a 
high pulmonary capillary wedge pressure.
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Drug Classification Dose Receptor Effects Onset Advantages Disadvantages
Noradrenaline Vasopressor IV:0.02 – 
0.2mcg/kg/min
1, 1 Vasoconstriction
SVR, 
Myocardial O2 delivery
PVR
Quick 
(mins)
Cheap
Easy to titrate
Familiarity
Arrhythmias
 PVR in 
higher doses 
Vasopressin Vasopressor IV.: 1-4 
units/min 
V1, V2 Vasoconstriction, SVR, 
Pulmonary 
vasodilatation at low 
doses via endothelial 
nitric oxide pathway
myocardial O2 delivery
Quick 
(mins)
Catecholamine sparing
Less  PVR than 
Noradrenaline
Easy to titrate
Expensive
Bradycardia
Splanchnic 
ischaemia
Dobutamine Inodilator IV: 2.5-
10mcg/kg/min
1,2 Inotropy
contractility 
SVR, PVR
Quick 
(mins)
Easy to titrate
Cheap
  O2 demand 
Tachy-
arrhythmias
Systemic 
hypotension 
Milrinone Inodilator IV 0.375–0.75 
mcg/kg/mina
PDE3 
inhibitor
Inotropy
Contractility
SVR, PVR
Long 
half-
life 
(2.5h)
Pulmonary vasodilatation Systemic 
hypotension
Expensive
Levosimendan Inodilator IV loading: 6–
12 mcg/kg/min 
over 10 min 
followed by 
0.1 
Calcium 
sensitizer
Contractility Slow No effect on myocardial 
oxygen demand
Expensive
Tachycardia
Hypotension
Headache
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mcg/kg/min 
Sildenafil Pulmonary 
vasodilator
IV: 10mg TDS
Oral: 20–
100 mg TDS
PDE5 
inhibitor
PVR
Contractility
Slow Oral admin for patients 
with chronic disease. 
Long terminal 
half-life (4-
18h), ↓SVR 
Epoprostenol Pulmonary 
vasodilator
IV:1-
2ng/kg/min
Neb: 0.2–
0.3 ml/min of 
10–20 µg/ml
Prostacyclin PVR
V/Q mismatch
Quick As efficient as nitric oxide Systemic 
hypotension 
with IV admin
Flushing
Headaches
Table 1. Commonly used pharmacological agents in RV failure. 
IV: intravenous. Neb: Nebulised. SVR: systemic vascular resistance. PVR: pulmonary vascular resistance. PH: Pulmonary hypertension. a A 
loading dose of milrinone may be given but increases risk of systemic hypotension. 
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Management￿of￿Acute￿Right￿Ventricular￿
Failure
In￿all￿cases￿identify￿and￿treat￿underlying￿aetiologies￿
where￿possible
Maintain￿rate￿
and￿rhythm:
Higher￿HR
Aim￿to￿
maintain￿SR
Cardioversion￿
if￿new￿
onset/instabilit
y
Amiodarone￿+/
-￿DCCV￿
Optimise￿Preload:
Optimise￿cardiac￿
filling
Under-filled:￿Small￿
fluid￿boluses￿(50-
100ml,￿close￿
attention￿to￿CVP)
Overfilled:￿
Diuresis￿with￿loop￿
diuretics
CVVH￿may￿be￿
required
Improve￿
contractility￿and￿
maintain￿
perfusion:
Inodilators￿
(dobutamine,￿
milrinone)
Vasopressors￿
(noradrenaline,￿
vasopressin)
Reduce￿afterload:
Prevent￿hypoxia,￿
hypercapnia,￿
acidosis
Reduce￿PEEP￿and￿
airway￿pressures
Avoid￿atelectasis
Inhaled￿
pulmonary￿
vasodilators
Intravenous￿
pulmonary￿
vasodilators￿
Mechanical￿
Circulatory￿
Support:
IABP
ECMO
VAD
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Figure 2. Schematic representation of the relationship between lung volume and pulmonary vascular 
resistance. 
The relationship of PVR and lung volumes. Atelectasis compresses extra-alveolar bloods vessels which 
increases PVR. Alveolar distention, occurring at high lung volumes, compresses intra-alveolar blood vessels 
which increases PVR. 
RV - Residual volume (RV). Functional Residual Capacity (FRC). Total Lung Capacity (TLC). 
176x196mm (72 x 72 DPI) 
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